Publications

  1. Degnim AC, Hoskin TL, Brahmbhatt RD, Warren-Peled A, Loprinzi M, Pavey ES, Boughey JC, Hieken TJ, Jacobson S, Lemaine V, Jakub JW, Irwin C, Foster RD, Sbitany H, Saint-Cyr M, Duralde E, Ramaker S, Chin R, Sieg M, Wildeman M, Scow JS, Patel R, Ballman K, Randomized Trial of Drain Antisepsis After Mastectomy and Immediate Prosthetic Breast Reconstruction. Ann Surg Oncol. 2014 Aug 06.
    View PubMed
  2. Brown L, Harmsen W, Blanchard M, Goetz M, Jakub J, Mutter R, Petersen I, Rooney J, Stauder M, Yan E, Laack N. Once-daily radiation therapy for inflammatory breast cancer. Int J Radiat Oncol Biol Phys. 2014 Aug 1; 89(5):997-1003. Epub 2014 Apr 07.
    View PubMed
  3. Fahy AS, Jakub JW, Dy BM, Eldin NS, Harmsen S, Sviggum H, Boughey JC. Paravertebral Blocks in Patients Undergoing Mastectomy with or without Immediate Reconstruction Provides Improved Pain Control and Decreased Postoperative Nausea and Vomiting. Ann Surg Oncol. 2014 Jul 18.
    View PubMed
  4. Boughey JC, Hieken TJ, Jakub JW, Degnim AC, Grant CS, Farley DR, Thomsen KM, Osborn JB, Keeney GL, Habermann EB. Impact of analysis of frozen-section margin on reoperation rates in women undergoing lumpectomy for breast cancer: evaluation of the National Surgical Quality Improvement Program data. Surgery. 2014 Jul; 156(1):190-7. Epub 2014 Mar 18.
    View PubMed
  5. Grotz TE, Huebner M, Pockaj BA, Perkins S, Jakub JW. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol. 2013 Dec; 20(13):4370-7. Epub 2013 Sep 18.
    View PubMed
  6. Degnim AC, Scow JS, Hoskin TL, Miller JP, Loprinzi M, Boughey JC, Jakub JW, Throckmorton A, Patel R, Baddour LM. Randomized controlled trial to reduce bacterial colonization of surgical drains after breast and axillary operations. Ann Surg. 2013 Aug; 258(2):240-7.
    View PubMed
  7. Kottschade LA, Grotz TE, Dronca RS, Salomao DR, Pulido JS, Wasif N, Jakub JW, Bagaria SP, Kumar R, Kaur JS, Morita SY, Moran SL, Nguyen JT, Nguyen EC, Hand JL, Erickson LA, Brewer JD, Baum CL, Miller RC, Swanson DL, Lowe V, Markovic SN. Rare Presentations of Primary Melanoma and Special Populations: A Systematic Review. Am J Clin Oncol. 2013 Apr 03. [Epub ahead of print]
    View PubMed
  8. Grotz TE, Glorioso JM, Pockaj BA, Harmsen WS, Jakub JW. Preservation of the deep muscular fascia and locoregional control in melanoma. Surgery. 2013 Apr; 153(4):535-41. Epub 2012 Dec 04.
    View PubMed
  9. Tarantola TI, Vallow LA, Halyard MY, Weenig RH, Warschaw KE, Grotz TE, Jakub JW, Roenigk RK, Brewer JD, Weaver AL, Otley CC. Prognostic factors in Merkel cell carcinoma: analysis of 240 cases. J Am Acad Dermatol. 2013 Mar; 68(3):425-32. Epub 2012 Nov 27.
    View PubMed
  10. Grotz TE, Kottschade L, Pavey ES, Markovic SN, Jakub JW. Adjuvant GM-CSF Improves Survival in High-risk Stage IIIC Melanoma: A Single-center Study. Am J Clin Oncol. 2013 Feb 20. [Epub ahead of print]
    View PubMed
  11. Abbott AM, Grotz TE, Rueth NM, Hernandez Irizarry RC, Tuttle TM, Jakub JW. Minimally invasive inguinal lymph node dissection (MILND) for melanoma: experience from two academic centers. Ann Surg Oncol. 2013 Jan; 20(1):340-5. Epub 2012 Aug 9
    View PubMed
  12. Graham RP, Jakub JW, Brunette JJ, Reynolds C. Handling of radioactive seed localization breast specimens in the pathology laboratory. Am J Surg Pathol. 2012 Nov; 36(11):1718-23.
    View PubMed
  13. Brahmbhatt RD, Huebner M, Scow JS, Harmsen WS, Boughey JC, Harris AM, Goede D, Jakub JW, Hieken TJ, Degnim AC. National practice patterns in preoperative and postoperative antibiotic prophylaxis in breast procedures requiring drains: survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2012 Oct; 19(10):3205-11. Epub 2012 Jul 06.
    View PubMed
  14. Shah-Khan MG, Geiger XJ, Reynolds C, Jakub JW, Deperi ER, Glazebrook KN. Long-term follow-up of lobular neoplasia (atypical lobular hyperplasia/lobular carcinoma in situ) diagnosed on core needle biopsy. Ann Surg Oncol. 2012 Oct; 19(10):3131-8. Epub 2012 Jul 31.
    View PubMed
  15. Lovely JK, Nehring SA, Boughey JC, Degnim AC, Donthi R, Harmsen WS, Jakub JW. Balancing venous thromboembolism and hematoma after breast surgery. Ann Surg Oncol. 2012 Oct; 19(10):3230-5. Epub 2012 Jul 21.
    View PubMed
  16. Ansari B, Boughey JC, Adamczyk DL, Degnim AC, Jakub JW, Morton MJ. Should axillary ultrasound be used in patients with a preoperative diagnosis of ductal carcinoma in situ? Am J Surg. 2012 Sep; 204(3):290-3. Epub 2012 Jun 30.
    View PubMed
  17. Grotz TE, Tarantola TI, Otley CC, Weaver AL, McGree ME, Jakub JW. Natural history of merkel cell carcinoma following locoregional recurrence. Ann Surg Oncol. 2012 Aug; 19(8):2556-62. Epub 2012 Mar 28.
    View PubMed
  18. Erben Y, Ghosh K, Nassar A, Gimenez E, Jakub JW. Invasive lobular carcinoma of the nipple. Breast J. 2012 May-Jun; 18(3):280-1. Epub 2012 Apr 05.
    View PubMed
  19. Drackley NL, Degnim AC, Jakub JW, Cutshall SM, Thomley BS, Brodt JK, Vanderlei LK, Case JK, Bungum LD, Cha SS, Bauer BA, Boughey JC. Effect of massage therapy for postsurgical mastectomy recipients. Clin J Oncol Nurs. 2012 Apr; 16(2):121-4.
    View PubMed
  20. Miles RC, Gullerud RE, Lohse CM, Jakub JW, Degnim AC, Boughey JC. Local recurrence after breast-conserving surgery: multivariable analysis of risk factors and the impact of young age. Ann Surg Oncol. 2012 Apr; 19(4):1153-9. Epub 2011 Oct 12.
    View PubMed
  21. Diaz R, Degnim AC, Boughey JC, Nassar A, Jakub JW. A positive intramammary lymph node does not mandate a complete axillary node dissection. Am J Surg. 2012 Feb; 203(2):151-5. Epub 2011 Jul 23.
    View PubMed
  22. Grotz TE, Mansfield AS, Jakub JW, Markovic SN. Regional lymphatic immunity in melanoma. Melanoma Res. 2012 Feb; 22(1):9-18.
    View PubMed
  23. Grotz TE, Kottschade L, Pavey ES, Markovic SN, Jakub JW. Adjuvant GM-CSF Improves Survival in High Risk Stage IIIC Melanoma: A Single Center Study. American Journal of Clinical Oncology. 2012.
  24. Grotz TE, Mansfield AS, Kottschade LA, Erickson LA, Otley CC, Markovic SN, Jakub JW. In-transit melanoma: an individualized approach. Oncology (Williston Park). 2011 Dec; 25(14):1340-8.
    View PubMed
  25. Reynolds C, Davidson JA, Lindor NM, Glazebrook KN, Jakub JW, Degnim AC, Sandhu NP, Walsh MF, Hartmann LC, Boughey JC. Prophylactic and therapeutic mastectomy in BRCA mutation carriers: can the nipple be preserved? Ann Surg Oncol. 2011 Oct; 18(11):3102-9. Epub 2011 Sep 27.
    View PubMed
  26. Osborn JB, Keeney GL, Jakub JW, Degnim AC, Boughey JC. Cost-effectiveness analysis of routine frozen-section analysis of breast margins compared with reoperation for positive margins. Ann Surg Oncol. 2011 Oct; 18(11):3204-9. Epub 2011 Aug 23.
    View PubMed
  27. Ansari B, Morton MJ, Adamczyk DL, Jones KN, Brodt JK, Degnim AC, Jakub JW, Lohse CM, Boughey JC. Distance of breast cancer from the skin and nipple impacts axillary nodal metastases. Ann Surg Oncol. 2011 Oct; 18(11):3174-80. Epub 2011 Aug 23.
    View PubMed
  28. Grotz TE, Markovic SN, Erickson LA, Harmsen WS, Huebner M, Farley DR, Pockaj BA, Donohue JH, Sim FH, Grant CS, Bagaria SP, Shives TC, Balch CM, Jakub JW, Mayo Clinic. Mayo Clinic consensus recommendations for the depth of excision in primary cutaneous melanoma. Mayo Clin Proc. 2011 Jun; 86(6):522-8.
    View PubMed
  29. Mansfield AS, Holtan SG, Grotz TE, Allred JB, Jakub JW, Erickson LA, Markovic SN. Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis. Mod Pathol. 2011 Apr; 24(4):487-94. Epub 2010 Dec 10.
    View PubMed
  30. Jakub JW, Bryant K, Huebner M, Hoskin T, Boughey JC, Reynolds C, Degnim AC. The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes. Ann Surg Oncol. 2011 Jan; 18(1):86-93. Epub 2010 Jul 01.
    View PubMed
  31. Jakub JW, Boughey JC. Sentinel lymph node biopsy after chemotherapy. Current Breast Cancer Reports. 2011; 3(2):97-103.
  32. Thanarajasingam U, Chen B, Tortorelli CL, Jakub JW, Ghosh K. Diabetic mastopathy as a radiographically occult palpable breast mass. Case Rep Med. 2011; 2011:162350. Epub 2011 Nov 03.
    View PubMed
  33. Thanarajasingam U, Chen B, Tortorelli CL, Jakub JW, Ghosh K. Case Report: Diabetic Mastopathy as a Radiographically Occult Palpable Breast Mass. Case Reports in Medicine. 2011.
  34. Mani A, Franco SX, Wang G, Abramson N, Schwartzberg LS, Jakub J, Tan-Chiu E, Schwartz MA, Frankel C, Krill-Jackson EA, Stein A, Perez AT, Vogel CL. A phase II tolerability trial of neoadjuvant docetaxel with carboplatin and capecitabine in locally advanced breast cancer. Community Oncol. 2011; 8(5):209-15.
  35. Fedko MG, Scow JS, Shah SS, Reynolds C, Degnim AC, Jakub JW, Boughey JC. Pure tubular carcinoma and axillary nodal metastases. Ann Surg Oncol. 2010 Oct; 17 Suppl 3:338-42. Epub 2010 Sep 19.
    View PubMed
  36. Pockaj BA, Wasif N, Dueck AC, Wigle DA, Boughey JC, Degnim AC, Gray RJ, McLaughlin SA, Northfelt DW, Sticca RP, Jakub JW, Perez EA. Metastasectomy and surgical resection of the primary tumor in patients with stage IV breast cancer: time for a second look? Ann Surg Oncol. 2010 Sep; 17(9):2419-26. Epub 2010 Mar 16.
    View PubMed
  37. Boughey JC, Donohue JH, Jakub JW, Lohse CM, Degnim AC. Number of lymph nodes identified at axillary dissection: effect of neoadjuvant chemotherapy and other factors. Cancer. 2010 Jul 15; 116(14):3322-9.
    View PubMed
  38. Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010 Apr 1; 101(5):401-7.
    View PubMed
  39. Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010 Apr; 199(4):522-8. Epub 2009 Dec 2
    View PubMed
  40. Grotz TE, Tortorelli CL, Degnim AC, Boughey JC, Whaley DH, Jakub JW. The use of radioactive seed localization for non-palpable non-breast lesions. Journal of Surgical Radiology. 2010; 1(2).
  41. Jakub JW, Russell G, Tillman CL, Lariscy C. Colon cancer and low lymph node count: who is to blame? Arch Surg. 2009 Dec; 144(12):1115-20.
    View PubMed
  42. Jakub JW, Huebner M, Shivers S, Nobo C, Puleo C, Harmsen WS, Reintgen DS. The number of lymph nodes involved with metastatic disease does not affect outcome in melanoma patients as long as all disease is confined to the sentinel lymph node. Ann Surg Oncol. 2009 Aug; 16(8):2245-51. Epub 2009 Jun 11.
    View PubMed
  43. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study Group of the Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26.
    View PubMed
  44. McDermott DF, Sosman JA, Gonzalez R, Hodi FS, Linette GP, Richards J, Jakub JW, Beeram M, Tarantolo S, Agarwala S, Frenette G, Puzanov I, Cranmer L, Lewis K, Kirkwood J, White JM, Xia C, Patel K, Hersh E. Double-blind randomized phase II study of the combination of sorafenib and dacarbazine in patients with advanced melanoma: a report from the 11715 Study Group. J Clin Oncol. 2008 May 1; 26(13):2178-85.
    View PubMed
  45. Shivers S, Jakub J, Pendas S, Reintgen D. Molecular staging for patients with malignant melanoma. Expert Rev Anticancer Ther. 2007 Nov; 7(11):1665-74.
    View PubMed
  46. Jakub JW, Reintgen DS, Shivers S, Pendas S. Regional node dissection for melanoma: techniques and indication. Surg Oncol Clin N Am. 2007 Jan; 16(1):247-61.
    View PubMed
  47. Leong SP, Cady B, Jablons DM, Garcia-Aguilar J, Reintgen D, Jakub J, Pendas S, Duhaime L, Cassell R, Gardner M, Giuliano R, Archie V, Calvin D, Mensha L, Shivers S, Cox C, Werner JA, Kitagawa Y, Kitajima M. Clinical patterns of metastasis. Cancer Metastasis Rev. 2006 Jun; 25(2):221-32.
    View PubMed
  48. Jakub JW, Garcia E, Giuliano R, Pendas S, Reintgen D. A black SLN in a melanoma patient. Contemp Surg. 2005; 61(8):403-5.
  49. Jakub JW, Ebert MD, Cantor A, Gardner M, Reintgen DS, Dupont EL, Cox CE, Shons AR. Breast cancer in patients with prior augmentation: presentation, stage, and lymphatic mapping. Plast Reconstr Surg. 2004 Dec; 114(7):1737-42.
    View PubMed
  50. Diaz NM, Cox CE, Ebert M, Clark JD, Vrcel V, Stowell N, Sharma A, Jakub JW, Cantor A, Centeno BA, Dupont E, Muro-Cacho C, Nicosia S. Benign mechanical transport of breast epithelial cells to sentinel lymph nodes. Am J Surg Pathol. 2004 Dec; 28(12):1641-5.
    View PubMed
  51. Shivers S, Alsarraj M, Guiliano R, Jakub J, Pendas S, Reintgen D. Molecular staging of melanoma. Ann Surg Oncol. 2004 Nov; 11(11):953-4.
    View PubMed
  52. Pendas S, Jakub J, Giuliano R, Gardner M, Swor GB, Reintgen DS. The role of sentinel lymph node biopsy in patients with ductal carcinoma in situ or with locally advanced breast cancer receiving neoadjuvant chemotherapy. Cancer Control. 2004 Jul-Aug; 11(4):231-5.
    View PubMed
  53. Pendas S, Giuliano R, Swor G, Gardner M, Jakub J, Reintgen DS. Worldwide experience with lymphatic mapping for invasive breast cancer. Semin Oncol. 2004 Jun; 31(3):318-23.
    View PubMed
  54. Reintgen D, Pendas S, Jakub J, Swor G, Giuliano R, Bauer J, Cassall R, Duhaime L, Alsarrai M, Shivers S. National trials involving lymphatic mapping for melanoma: the Multicenter Selective Lymphadenectomy Trial, the Sunbelt Melanoma Trial, and the Florida Melanoma Trial. Semin Oncol. 2004 Jun; 31(3):363-73.
    View PubMed
  55. Jakub JW, Cox CE, Pippas AW, Gardner M, Pendas S, Reintgen DS. Controversial topics in breast lymphatic mapping. Semin Oncol. 2004 Jun; 31(3):324-32.
    View PubMed
  56. Cox CE, Furman B, Dupont EL, Jakub JW, Stowell N, Clark J, Ebert M. Novel techniques in sentinel lymph node mapping and localization of nonpalpable breast lesions: the Moffitt experience. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):222S-6S.
    View PubMed
  57. Reintgen DS, Jakub JW, Pendas S, Swor G, Giuliano R, Shivers S. The staging of malignant melanoma and the Florida Melanoma Trial. Ann Surg Oncol. 2004 Mar; 11(3 Suppl):186S-91S.
    View PubMed
  58. Cox CE, White L, Stowell N, Clark J, Dickson D, Furman B, Weinberg E, Jakub J, Dupont E. Clinical considerations in breast cancer sentinel lymph node mapping: a Moffitt review. Breast Cancer. 2004; 11(3):225-32; discussion 264-6.
    View PubMed
  59. Jakub J, Pendas S, Swor G, Gardner M, Giuliano R, Reintgen D. "Ultrastaging" of breast cancer in the sentinel lymph node era. Clin Breast Cancer. 2004; 5(4):285-6.
  60. Jakub JW, Drake FD, Pippas AW, Gardner M, Fraile RJ, Giuliano R, Pendas S, Reintgen DS. A case report of invasive ductal adenocarcinoma identified in a lymphatic channel: a staging controversy. Cancer Control. 2003 Sep-Oct; 10(5):411-3.
    View PubMed
  61. Jakub JW, Ebert MD, Diaz NM, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE. Effect of lymphatic mapping on diagnosis and treatment of patients with T1a, T1b favorable breast cancer. Ann Surg. 2003 Jun; 237(6):838-41; discussion 841-3.
    View PubMed
  62. Jakub JW, Pendas S, Reintgen DS. Current status of sentinel lymph node mapping and biopsy: facts and controversies. Oncologist. 2003; 8(1):59-68.
    View PubMed
  63. Jakub JW, Diaz NM, Ebert MD, Cantor A, Reintgen DS, Dupont EL, Shons AR, Cox CE. Completion axillary lymph node dissection minimizes the likelihood of false negatives for patients with invasive breast carcinoma and cytokeratin positive only sentinel lymph nodes. Am J Surg. 2002 Oct; 184(4):302-6.
    View PubMed
  64. Gill SS, Jakub JW, Pease MC, Woollen CD. The economic impact of motor vehicle crashes: the cost of restrained versus unrestrained occupants in South Carolina. Am Surg. 2002 Jun; 68(6):569-74; discussion 574.
    View PubMed
  65. Cox CE, Jakub JW. Re: Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg. 2002 May; 68(5):500-2.
    View PubMed
  66. Jakub JW, Cox CE. The Ghosh/Hartmann article reviewed: current status of prophylactic mastectomy. Oncology. 2002; 16(10):1319-32.
  67. Jakub JW, Jackson LD, Bynoe RP. Renal cell carcinoma identified after blunt abdominal trauma. Surg Rounds. 2000:612-6.
  68. Jakub JW, Zamora SM, Greene FL. Laparoscopic cholecystostomy. J S C Med Assoc. 1996 Jul; 92(7):302-5.
    View PubMed